Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Nov-24 10:00 PM View:  | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-24 | Payment of Exercise | 402 | $7.92 | $3,183.84 | (2%) 17.36K to 16.96K | |
| 16-Aug-24 4:50 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Aug-24 | Payment of Exercise | 402 | $7.02 | $2,822.04 | (2%) 17.77K to 17.36K | |
| 16-May-24 6:58 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-May-24 | Payment of Exercise | 402 | $8.36 | $3,360.72 | (2%) 18.17K to 17.77K | |
| 16-Feb-24 5:10 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Feb-24 | Payment of Exercise | 468 | $3.40 | $1,591.20 | (3%) 18.64K to 18.17K | |
| 16-Nov-23 7:41 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-23 | Payment of Exercise | 1,395 | $5.08 | $7,086.60 | (7%) 20.03K to 18.64K | |
| 16-Nov-22 7:21 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-22 | Grant | 20,030 | -- | -- | 100% 0 to 20.03K |